FLUPEMI
Live / Allowed — Notice of allowance issued (as of 02 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98581130
- Mark type
- Stylized text
- Filed
- 03 Jun 2024
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Sept 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 08 Apr 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 08 Apr 2025 — LETTER OF SUSPENSION E-MAILED
- 08 Apr 2025 — SUSPENSION LETTER WRITTEN
- 07 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Apr 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 04 Mar 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED